These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17002658)

  • 1. Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion.
    Wong AY; Hewitt J; Clarke BJ; Hudson DM; Krisinger MJ; Dower NA; MacGillivray RT
    J Thromb Haemost; 2006 Dec; 4(12):2623-8. PubMed ID: 17002658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A severe neonatal presentation of factor II deficiency.
    Pasmant E; Dumont B; Lacapere JJ; Dautzenberg MD; Bezeaud A
    Eur J Haematol; 2011 Nov; 87(5):464-6. PubMed ID: 21692854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.
    Mizukami K; Nakabayashi T; Naitoh S; Takeda M; Tarumi T; Mizoguchi I; Ieko M; Koike T
    Am J Hematol; 2006 Oct; 81(10):787-97. PubMed ID: 16868938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prothrombin deficiency resulted from a homozygous Glu29 to Gly mutation in the prothrombin gene].
    Wang WB; Wang HL; Huang CY; Fang Y; Fu QH; Zhou RF; Xie S; Ding QL; Wu WM; Wang XF; Hu YQ; Wang ZY
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):449-51. PubMed ID: 14575584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder.
    Poort SR; Michiels JJ; Reitsma PH; Bertina RM
    Thromb Haemost; 1994 Dec; 72(6):819-24. PubMed ID: 7740448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362 --> Thr (Prothrombin Vellore 1) mutation.
    Jayandharan G; Viswabandya A; Baidya S; Nair SC; Shaji RV; Chandy M; Srivastava A
    J Thromb Haemost; 2005 Jul; 3(7):1446-53. PubMed ID: 15892853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia.
    Sun WY; Burkart MC; Holahan JR; Degen SJ
    Blood; 2000 Jan; 95(2):711-4. PubMed ID: 10627484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly.
    Wang W; Fu Q; Zhou R; Wu W; Ding Q; Hu Y; Wang X; Wang H; Wang Z
    Haemophilia; 2004 Jan; 10(1):94-7. PubMed ID: 14962227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genetic analysis of a compound heterozygote for dys- and hypoprothrombinaemia.
    Akhavan S; Luciani M; Lavoretano S; Mannucci PM
    Br J Haematol; 2003 Jan; 120(1):142-4. PubMed ID: 12492590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient.
    Poort SR; Njo KT; Vos HL; Bertina RM
    Blood Coagul Fibrinolysis; 1998 Nov; 9(8):761-4. PubMed ID: 9890721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin.
    Rouy S; Vidaud D; Alessandri JL; Dautzenberg MD; Venisse L; Guillin MC; Bezeaud A
    Br J Haematol; 2006 Mar; 132(6):770-3. PubMed ID: 16487178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common mutation, Arg457-->Gln, links prothrombin deficiencies in the Puerto Rican population.
    Lefkowitz JB; Weller A; Nuss R; Santiago-Borrero PJ; Brown DL; Ortiz IR
    J Thromb Haemost; 2003 Nov; 1(11):2381-8. PubMed ID: 14629473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency.
    Poort SR; Landolfi R; Bertina RM
    Thromb Haemost; 1997 Apr; 77(4):610-5. PubMed ID: 9134629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of a compound heterozygote for hypoprothrombinemia and dysprothrombinemia (-G 7248/7249 and ARG 340 TRP).
    Tamary H; Surrey S; Augustine J; Shalmon L; Schwartz E; Rappaport EF
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):337-43. PubMed ID: 9351523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency.
    Akhavan S; Mannucci PM; Lak M; Mancuso G; Mazzucconi MG; Rocino A; Jenkins PV; Perkins SJ
    Thromb Haemost; 2000 Dec; 84(6):989-97. PubMed ID: 11154146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.
    Iwahana H; Yoshimoto K; Shigekiyo T; Shirakami A; Saito S; Itakura M
    Am J Hum Genet; 1992 Dec; 51(6):1386-95. PubMed ID: 1334372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia.
    Henriksen RA; Dunham CK; Miller LD; Casey JT; Menke JB; Knupp CL; Usala SJ
    Blood; 1998 Mar; 91(6):2026-31. PubMed ID: 9490687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
    O'Marcaigh AS; Nichols WL; Hassinger NL; Mullins JD; Mallouh AA; Gilchrist GS; Owen WG
    Blood; 1996 Oct; 88(7):2611-8. PubMed ID: 8839854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation (C571T) in the tissue-non-specific alkaline phosphatase gene in a case of adult-type hypophosphatasia.
    Watanabe H; Hashimoto-Uoshima M; Goseki-Sone M; Orimo H; Ishikawa I
    Oral Dis; 2001 Nov; 7(6):331-5. PubMed ID: 11834095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia.
    Sun WY; Smirnow D; Jenkins ML; Degen SJ
    Thromb Haemost; 2001 Apr; 85(4):651-4. PubMed ID: 11341500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.